XBI icon

SPDR S&P Biotech ETF
XBI

Overview Fund Activity

660 hedge funds and large institutions have $9.04B invested in SPDR S&P Biotech ETF in 2021 Q2 according to their latest regulatory filings, with 81 funds opening new positions, 247 increasing their positions, 178 reducing their positions, and 59 closing their positions.

Holders
660
Holders Change
+19
Holders Change %
+2.96%
% of All Funds
11.52%
Holding in Top 10
17
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-15%
% of All Funds
0.3%
New
81
Increased
247
Reduced
178
Closed
59
Calls
$1.39B
Puts
$2.37B
Net Calls
-$978M
Net Calls Change
+$600M

Top Buyers

1
Toronto Dominion Bank
1
Toronto Dominion Bank
Ontario, Canada
$864M
2
O
2
OrbiMed
New York
$127M
3
Canada Pension Plan Investment Board
3
Canada Pension Plan Investment Board
Ontario, Canada
$135M
4
CS
4
Credit Suisse
Switzerland
$48.6M
5
CI
5
Clal Insurance
Israel
$62.3M

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$537M
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$492M
3
Goldman Sachs
3
Goldman Sachs
New York
$819M
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$616M
5
Bank of America
5
Bank of America
North Carolina
$843M
Name Market Value Shares Shares
Change 		Shares
Change %
GPCM
751
Granite Point Capital Management
Massachusetts
– – – –
BMCM
752
Black Maple Capital Management
Wisconsin
– – – –
PHS
753
PFM Health Sciences
California
– – – –
LCM
754
Laurion Capital Management
New York
– – – –
CM
755
Caption Management
Oklahoma
– – – –
ACM
756
Aquilo Capital Management
California
– – – –
HCP
757
Hexagon Capital Partners
Arkansas
$0 1 +1 New
27 28 29 30
31